Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled platelet activation to monitor therapy of ADP antagonists

Controlled platelet activation to monitor therapy of ADP antagonists

US Patent 9341637 · Granted May 17, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydronaphthyridinepentanamide integrin antagonists2021
Methods of treating sickle cell disease2019
Pulsed-neutron tool methods and systems for monitoring casing corrosion2017
Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines2017
Methods for measuring platelet reactivity of individuals treated with drug eluti2016
Methods for measuring platelet reactivity of individuals treated with drug eluti2016
7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatmen2016
Alpha-IIb-beta-3 inhibitors and uses thereof2015
Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines2015
Controlled platelet activation to monitor therapy of ADP antagonists2013
Controlled platelet activation to monitor therapy of ADP antagonists2013
Alpha-IIB-beta-3 inhibitors and uses thereof2012